Risk Estimation for Healthy Women from Breast Cancer Families: New Insights and New Strategies

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 87-93

  Van Asperen, Christi J ^a   Jonker, M A ^a   Jacobi, C E ^a   Van Diemen Homan, J E M ^a   Bakker, E ^a   Breuning, M H ^a   Van Houwelingen, J C ^a   De Bock, G H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CLAUS MODEL; CLINICAL PRACTICE; FAMILIAL CANCER; FEMALE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MODEL; OVARY CANCER; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT;

BREAST NEOPLASMS; FAMILY; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; LOGISTIC MODELS; MALE; OVARIAN NEOPLASMS; RISK ASSESSMENT;

EID: 1642568705     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0090     Document Type: Article

References (32)

1. Rosser, E. M., Hurst, J. A., and Chapman, C. J. Cancer families: what risks are they given and do the risks affect management? J. Med. Genet., 33: 977-980, 1996.
2. Tischkowitz, M., Wheeler, D., France, E., Chapman, C., Lucassen, A., Sampson, J., Harper, P., Krawczak, M., and Gray, J. A comparison of methods currently used in clinical practice to estimate familial breast cancer risks. Ann. Oncol., 11: 451-454, 2000.
3. McTiernan, A., Kuniyuki, A., Yasui, Y., Bowen, D., Burke, W., Culver, J. B., Anderson, R., and Durfy, S. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol. Biomark. Prev., 10: 333-338, 2001.
4. Shannon, K. M., Lubratovich, M. L., Finkelstein, D. M., Smith, B. L., Powell, S. N., and Seiden, M. V. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer (Phila.), 94: 305-313, 2002.
5. Couch, F. J., DeShano, M. L., Blackwood, M. A., Clazone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B. L. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med., 336: 1409-1415, 1997.
6. Shattuck-Eidens, D., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., Pruss, D., et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA., 278: 1242-1250, 1997.
7. Parmigiani, G., Berry, D., and Aguilar, O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am. J. Hum. Genet., 62: 145-158. 1998.
8. Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., and Critchfield, G. C. Clinical characteristics of individuals with germline mutations, in BRCA1 and BRCA2: analysis of 10,000 individuals. J. Clin. Oncol., 20: 1480-1490, 2002.
9. Nathanson, K. N., Wooster, R., and Weber, B. L. Breast cancer genetics: what we know and what we need. Nat. Med., 7: 552-556, 2001.
10. Claus, E. B., Risch, N., and Thompson, W. D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet., 48: 232-242, 1991.
11. Claus, E. B., Risch, N., and Thompson, W. D. Autosomal dominant inheritance of early onset breast cancer. Cancer (Phila.), 73: 643-651, 1994.
12. Hoskins, K. F., Stopfer, J. E., Calzone, K. A., Merajver, S. D., Rebeck, T. R., Garber, J. E., et al. Estimation and counseling for women with a family history of breast cancer. JAMA. 273: 577-585, 1995.
13. De Bock, G. H., Vliet Vlieland, T. P. M., Hageman, G. C. H. A., Oosterwijk, J. C., Springer, M. P., and Kievit, J. The estimation of genetic risk of breast cancer: a set of GP guidelines. Fam. Pract., 16: 71-77, 1999.
14. Eccles, D. M., Evans, D. G., and Mackay, J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J. Med. Genet., 37: 203-209, 2000.
15. Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., and Mulvihill. J. J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer. Inst. (Bethesda), 81: 1879-1886, 1989.
16. Weitzel, J. N. Genetic cancer risk estimation. Putting it all together. Cancer (Phila.), 86: 2483-249l, 1999.
17. Claus, E. B., Risch, N., and Thompson, W. D. The calculation of breast cancer risk for women with a First degree family history of ovarian cancer. Breast Cancer Res. Treat., 28: 115-120, 1993.
18. Jonker, M. A., Jacobi, C. E., Hoogendoorn, W. E., Nagelkerke, N. J. D., de Bock, G. H., and van Houwelingen, J. C. Modeling familial clustered breast cancer using published data. Cancer Epidemiol. Biomark. Prev., in press.
19. Van Asperen, C. J., van Dijk, S., Zoeteweij, M. W., Timmermans, D. R. M., de Bock, G. H., Meijers-Heijboer, E. J., Niermeijer, M. F., Breuning, M. H., Kievit, J., and Otten, W. What do women really want to know? Motives for attending familial breast cancer clinics. J. Med. Genet., 39: 410-414, 2002.
20. Ford, D., Easton, D. F., and Peto, J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet., 57: 1457-1462. 1995.
21. Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., and Stratton, M. R. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J. Natl. Cancer. Inst. (Bethesda), 91: 943-949, 1999.
22. Easton, D. F., Ford, D., and Bishop, D. T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 56: 265-271. 1995.
23. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., and Zelada-Hedman, M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 62: 676-689, 1998.
24. Berry, D. A., Iversen, E. S., Jr., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., Rubinstein, W. S., Hughes, K. S., and Parmigiani, G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J. Clin. Oncol., 20: 2701-2712, 2002.
25. Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Straton, M. R., Peto, J., Ponder, B. J., and Easton, D. F. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer, 86: 76-83, 2002.
26. Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Ponder, B. A. J., and Easton, D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol., 21: 1-18, 2001.
27. Cui, J., Antoniou, A. C., Dite, G. S., Southey, M. C., Venter, D. J., Easton, D. F., Giles, G. G., McCredie, M. R. E., and Hopper, J. L. After BRCA1 and BRCA2 - what next? Multifactorial segregation analysis of three-generation, population-based Australian families affected by female breast cancer. Am. J. Hum. Genet., 68: 420-431, 2001.
28. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet, 358: 1389-1399, 2001.
29. Liede, A., Tonin, P. N., Sun, C. C., Serruya, C., Daly, M. B., Narod, S. A., and Foulkes, W. D. Is hereditary site-specific ovarian cancer a distinct genetic condition? Am. J. Med. Genet., 75: 55-58, 1998.
30. Reedy, M., Gallion, H., Fowler, J. M., Kryscio, R., and Smith, S. A. Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Gynaecol. Oncol., 85: 255-259, 2002.
31. Jonker, M. A., De Bock, G. H., Hoogendoorn, W. E., Van Asperen, C. J., and van Houwelingen, J. C. Little value from including cousins in individual risk assessment of hereditary breast cancer. A simulation study. J. Med. Genet., 40: e-25, 2003.
32. Euhus, D. M. Understanding mathematical models for breast cancer risk estimation and counseling. Breast J., 7: 224-232, 2001.